Introduction: Alzheimer’s disease (AD) is characterized by the accumulation of amyloid-beta (Aβ) peptides, which contribute to synaptic dysfunction, neuronal toxicity, and gene expression alterations.
“This study highlights the influence of blood in AD pathology and the identification of potential therapeutic targets.” Alzheimer’s disease is a progressive neurodegenerative disorder characterized by ...
NXC-201 therapy showed significant responses in relapsed/refractory AL amyloidosis, with 95% achieving disease marker normalization and 75% complete responses. The therapy was well-tolerated, with low ...
A new study identifies a biological process that empowers specific brain cells to eliminate harmful proteins associated with Alzheimer’s disease. By increasing the levels of a specific regulatory ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback